Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting

New analysis highlights BOT/BAL activity across challenging metastatic disease sites

...

Related Keywords

United States ,American ,Marwan Fakih ,City Of Hope Comprehensive Cancer Center ,Exchange Commission ,American Society Of Clinical Oncology ,Agenus Inc ,Division Head ,Clinical Oncology ,Annual Meeting ,Steveno Day ,Chief Medical Officer ,Hope Comprehensive Cancer Center ,Poster Session ,Gastrointestinal Cancer ,Risk Factors ,Annual Report ,Quarterly Reports ,